Your search returned 10 results.

Results
	1.	Characterization and elimination of a factor in serum that interferes with turbidimetry and nephelometry of lipase. [electronic resource] by Kannisto, H Lalla, M Lukkari, E Producer: 19830214 In: Clinical chemistry vol. 29 Availability: No items available. Save to lists Add to cart (remove)
	2.	The pharmacokinetics of oxybutynin is unaffected by gender and contraceptive steroids. [electronic resource] by Lukkari, E Hakonen, T Neuvonen, P J Producer: 19980430 In: European journal of clinical pharmacology vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Does beta-blockade provoke intermittent claudication? [electronic resource] by Lepäntalo, M Aromaa, A Klaukka, T Lukkari, E Producer: 19851118 In: Acta medica Scandinavica vol. 218 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin. [electronic resource] by Birns, J Lukkari, E Malone-Lee, J G Producer: 20000608 In: BJU international vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Cytochrome P450 specificity of metabolism and interactions of oxybutynin in human liver microsomes. [electronic resource] by Lukkari, E Taavitsainen, P Juhakoski, A Pelkonen, O Producer: 19980622 In: Pharmacology & toxicology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metabolite. [electronic resource] by Lukkari, E Juhakoski, A Aranko, K Neuvonen, P J Producer: 19970925 In: European journal of clinical pharmacology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Effect of time interval between food and drug ingestion on the absorption of oxybutynin from a controlled-release tablet. [electronic resource] by Lukkari, E Aranko, K Juhakoski, A Hakonen, T Neuvonen, P J Producer: 19970929 In: Pharmacology & toxicology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patients. [electronic resource] by Nilsson, C G Lukkari, E Haarala, M Kivelä, A Hakonen, T Kiilholma, P Producer: 19971216 In: Neurourology and urodynamics vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Effect of food on the bioavailability of oxybutynin from a controlled release tablet. [electronic resource] by Lukkari, E Castrèn-Kortekangas, P Juhakoski, A Löyttyniemi, E Aranko, K Neuvonen, P J Producer: 19970318 In: European journal of clinical pharmacology vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	The effect of taurocholate on canine bile flow, biliary excretion and concentration of ioglycamide. [electronic resource] by Tötterman, S Göthlin, J Santavirta, S Mankinen, P Korpi-Tommola, T Antila, H Lukkari, E Producer: 19830909 In: European journal of radiology vol. 3 Availability: No items available. Save to lists Add to cart (remove)